D. J. Slamom

Statistics

Publications

Citations

H-Index

Active since

2004

Affiliations

Loyola University Medical Center(Current)

McGill University

D. J. Slamom is an author at Loyola University Medical Center specializing in her2-positive breast cancer immunotherapy, metastatic her2-positive breast cancer, and breast cancer response assessment.

Publications per year

2004–2004

Publications

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

N. J. Robert, Brian Leyland‐Jones, Lina Asmar et al. · Journal of Clinical Oncology · 2004 · 32 citations

Medicine, Oncology, Pharmacology +17

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

N. J. Robert, Brian Leyland‐Jones, Lina Asmar et al. · Journal of Clinical Oncology · 2004 · 13 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2